Oura is a Finnish technology company and leading manufacturer of smart rings for health tracking. Founded in 2013 in Oulu, Finland, Oura gained widespread recognition for its Oura Ring—a sleek, wearable device that tracks sleep, activity, and physiological metrics. The company has expanded into enterprise health, research partnerships, and healthcare applications.
| Attribute |
Value |
| Founded |
2013 |
| Headquarters |
Oulu, Finland |
| CEO |
Tom Hale |
| Website |
ouraring.com |
| Stock |
Private |
The company's flagship product is a smart ring featuring:
- Infrared Sensors: Photoplethysmography (PPG) for heart rate monitoring
- Temperature Sensors: Skin temperature tracking
- 3D Accelerometer: Movement and activity tracking
- Battery: Up to 7 days of continuous monitoring
- Enhanced heart rate monitoring
- Improved sleep staging accuracy
- Blood oxygen (SpO2) sensing
- Skin temperature variability
- Oura App (iOS/Android)
- Oura Cloud Dashboard
- API for third-party integration
- Employer wellness programs
Oura Ring has shown promise in Parkinson's disease monitoring through:
- REM Sleep Behavior Disorder (RBD): Oura can detect abnormal movements during REM sleep, a common PD precursor
- Sleep Architecture Changes: Tracking sleep stages may reveal PD progression
- Nocturnal Hypoventilation: Monitoring respiratory patterns
- Resting heart rate trends
- Heart rate variability (HRV) analysis
- Activity levels and sedentary time
- Tremor detection (limited)
- HRV as a marker of autonomic dysfunction in PD
- Sleep temperature patterns
- Circadian rhythm analysis
¶ Research and Clinical Applications
Oura has been used in research settings for:
- Neurodegenerative disease biomarker discovery
- Sleep disorder characterization
- Post-surgical monitoring
- Circadian rhythm analysis in PD
- Academic medical center collaborations
- Sleep disorder clinics
- Neurology research programs
- FDA cleared for over-the-counter sleep apnea detection (2024)
- CE marked under EU MDR
- Class I/II medical device depending on feature
Oura's healthcare expansion includes:
- Precision Health: Individual baseline tracking
- Chronic Disease Management: Long-term condition monitoring
- Clinical Research: Biomarker discovery and validation
- Employer Wellness: Corporate health programs
RBD is a strong prodromal marker for Parkinson's disease, with approximately 50-80% of patients with idiopathic RBD eventually developing a synucleinopathy such as PD. Oura Ring's continuous temperature and movement monitoring enables:
- REM sleep without atonia detection: Identifying lack of normal muscle paralysis during REM sleep
- Nighttime movement patterns: Tracking irregular movements that characterize RBD
- Longitudinal monitoring: Detecting changes in sleep architecture over time that may indicate PD progression
- Temperature variability: Skin temperature drops during REM sleep; abnormal patterns may indicate autonomic dysfunction
Oura has established research collaborations with leading institutions:
- Michael J. Fox Foundation: Partnership for PD prodromal biomarker research
- Mayo Clinic: Sleep disorder detection and circadian rhythm analysis
- Stanford Neurology: Longitudinal studies of wearable biomarkers in PD
- University of Helsinki: Sleep architecture changes in neurodegenerative disease
| Study |
Institution |
Focus |
Status |
| PD Prodrome Study |
Multiple |
RBD + wearable biomarkers |
Ongoing |
| Sleep Architecture in PD |
Academic |
REM sleep analysis |
Published |
| Autonomic Biomarkers |
Clinical |
HRV + temperature variability |
Recruiting |
Oura competes with:
- Apple Watch
- Fitbit (Google)
- Whoop
- Samsung Galaxy Watch
- RingConn
Oura differentiates through:
- 24/7 wearability (ring form factor)
- Superior sleep tracking
- Longer battery life
- Minimalist design